当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • Google スカラー
  • シェルパ・ロミオ
  • Jゲートを開く
  • アカデミックキー
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

Post-Operative Outcome of Achilles Tendon Injury Treated with Knotless Percutaneous Achilles Repair System

Batra AV, O’Sullivan J, Nicholson D, Rao P

Background: The Achilles tendon is the most frequently ruptured tendon in the body and its incidence is increasing, more so among athletes. Various surgical techniques exist for treating it and one of these is as discussed in this study, Achilles tendon injury treated with Knotless PARS (Arthrex) that allows for earlier weight bearing and mobilization and, therefore, faster rehabilitation and an improved functional outcome.
Aim: The post-operative progress of patients, specifically athletes subset with Achilles tendon injury treated with Knotless PARS is discussed in this article using Newcastle Orthopaedic Foot and Ankle Score (NOFAS).
Methods: We retrospectively evaluated the patients operated on between March 2015 and January, 2017, 19 feet of 19 patients diagnosed with acute Achilles tendon rupture were treated. All clinical outcomes were examined using the Newcastle Orthopaedic Foot and Ankle Score (NOFAS) in patients operated in the last 28 months after the operation. We measured their progress in 3 categories as follows: (1) Improvement in pain and symptoms. (2) Recovery and lifestyle improvement and (3) Motion and activity.
Conclusion: The study suggests that the post-operative progress of patients with Achilles tendon injury treated with Knotless PARS (Arthrex) is strong, but the best results only appear in patients post 12 months of their surgery. We suggest, prospective and comparative studies will help for further research of this subject.